Contact
Please use this form to send email to PR contact of this press release:
Threshold Pharmaceuticals Receives Two U.S. Patents for Tarloxotinib Bromide
TO:
Please use this form to send email to PR contact of this press release:
Threshold Pharmaceuticals Receives Two U.S. Patents for Tarloxotinib Bromide
TO: